1. Home
  2. RNXT vs WIMI Comparison

RNXT vs WIMI Comparison

Compare RNXT & WIMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • WIMI
  • Stock Information
  • Founded
  • RNXT 2012
  • WIMI 2015
  • Country
  • RNXT United States
  • WIMI China
  • Employees
  • RNXT N/A
  • WIMI N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • WIMI Computer Software: Prepackaged Software
  • Sector
  • RNXT Health Care
  • WIMI Technology
  • Exchange
  • RNXT Nasdaq
  • WIMI Nasdaq
  • Market Cap
  • RNXT 44.6M
  • WIMI 38.3M
  • IPO Year
  • RNXT 2021
  • WIMI 2020
  • Fundamental
  • Price
  • RNXT $1.25
  • WIMI $3.91
  • Analyst Decision
  • RNXT Strong Buy
  • WIMI
  • Analyst Count
  • RNXT 2
  • WIMI 0
  • Target Price
  • RNXT $7.50
  • WIMI N/A
  • AVG Volume (30 Days)
  • RNXT 339.0K
  • WIMI 263.3K
  • Earning Date
  • RNXT 08-14-2025
  • WIMI 01-01-0001
  • Dividend Yield
  • RNXT N/A
  • WIMI N/A
  • EPS Growth
  • RNXT N/A
  • WIMI N/A
  • EPS
  • RNXT N/A
  • WIMI 1.00
  • Revenue
  • RNXT $662,000.00
  • WIMI $74,245,408.00
  • Revenue This Year
  • RNXT $2,988.37
  • WIMI N/A
  • Revenue Next Year
  • RNXT $300.60
  • WIMI N/A
  • P/E Ratio
  • RNXT N/A
  • WIMI $3.94
  • Revenue Growth
  • RNXT N/A
  • WIMI N/A
  • 52 Week Low
  • RNXT $0.75
  • WIMI $2.24
  • 52 Week High
  • RNXT $1.69
  • WIMI $29.20
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 62.94
  • WIMI 54.09
  • Support Level
  • RNXT $0.90
  • WIMI $3.85
  • Resistance Level
  • RNXT $0.95
  • WIMI $4.12
  • Average True Range (ATR)
  • RNXT 0.08
  • WIMI 0.22
  • MACD
  • RNXT 0.03
  • WIMI -0.00
  • Stochastic Oscillator
  • RNXT 86.54
  • WIMI 57.14

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About WIMI WiMi Hologram Cloud Inc.

WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.

Share on Social Networks: